Fletcher William A 4
4 · NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ · Filed Oct 29, 2009
Insider Transaction Report
Form 4
Fletcher William A
DirectorActing Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2009-10-27$0.65/sh+15,000$9,750→ 83,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-10-27−15,000→ 0 totalExercise: $0.65→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The Board of Directors of the Issuer approved acceleration of the vesting of all options so that the options become exercisable upon the approval of the dissolution of the Issuer by the stockholders. The stockholders of the Issuer approved the dissolution at a special meeting of stockholders held on October 27, 2009.
- [F2]Options will be terminated on the effective date of a certificate of dissolution of the Issuer to be filed with the Secretary of State of Delaware.